This content is Subscriber-Exclusive
You must have a National Geographic subscription to explore this article.
Premium Content
The FDA is evaluating the new diabetes drug Mounjaro as an obesity treatment, and early results show it takes the benefits of Ozempic up a notch. Here’s how they compare.